"We welcome the government's announcement in the Budget 2024-25 to fully exempt three additional cancer medicines from customs duties. This is a significant step towards making essential cancer treatments more accessible and affordable for patients across India," stated Mr. Negi. He emphasized that the high cost of cancer medications has been a major barrier for many patients, and this exemption will undoubtedly provide much-needed financial relief to those battling the disease.

Mr. Negi also praised the proposed reduction in the basic customs duty (BCD) on x-ray tubes and flat panel detectors for use in medical x-ray machines. "By aligning these changes with domestic capacity addition, the government is not only supporting the growth of local manufacturing but also ensuring that advanced medical technology is available to improve diagnostic accuracy and treatment outcomes for cancer patients," he noted.

Mr. Negi applauded the government's decisive measures and expressed confidence that these steps will bring the country closer to a future where every cancer patient has access to the best possible care.